NEW YORK (360Dx) – A team led by researchers at the Massachusetts Institute of Technology has developed a dipstick test for diagnosing Zika virus from patient serum.

The test, which is also able to distinguish between different dengue virus serotypes, could enable rapid, inexpensive testing for Zika and dengue infections, said Lee Gehrke, professor of health sciences and technology at MIT and one of the developers of the test.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.